Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,582 | -15,332 | -12,331 | -6,558 | -21,479 |
| Depreciation Amortization | 567 | 427 | 297 | 175 | 783 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -1,803 |
| Accounts receivable | 106 | 339 | 508 | 668 | -446 |
| Other Working Capital | -8,766 | -5,749 | -2,037 | -939 | -10,804 |
| Other Operating Activity | 3,583 | 3,569 | 2,604 | 871 | 5,183 |
| Operating Cash Flow | $-23,092 | $-16,746 | $-10,959 | $-5,783 | $-28,566 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18 | 18 | 18 | N/A | 196 |
| PPE Investments | -565 | -200 | -88 | -38 | -674 |
| Purchase Of Investment | -8,761 | -8,761 | -8,761 | N/A | -16,403 |
| Sale Of Investment | 7,000 | 4,000 | N/A | N/A | 63,330 |
| Investing Cash Flow | $-2,308 | $-4,943 | $-8,831 | $-38 | $46,449 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -54 | -40 | -27 | -13 | -54 |
| Common Stock Issued | 36,105 | 14,186 | 14,176 | 14,057 | 6,514 |
| Common Stock Repurchased | -23 | -23 | -23 | -23 | -37 |
| Other Financing Activity | -171 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $35,857 | $14,123 | $14,126 | $14,021 | $6,423 |
| Exchange Rate Effect | -95 | -120 | -158 | -70 | -250 |
| Beginning Cash Position | 35,992 | 35,992 | 35,992 | 35,992 | 11,936 |
| End Cash Position | 46,354 | 28,306 | 30,170 | 44,122 | 35,992 |
| Net Cash Flow | $10,362 | $-7,686 | $-5,822 | $8,130 | $24,056 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,092 | -16,746 | -10,959 | -5,783 | -28,566 |
| Capital Expenditure | -565 | -200 | -88 | -38 | -674 |
| Free Cash Flow | -23,657 | -16,946 | -11,047 | -5,821 | -29,240 |